Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Rubius Therapeutics Inc (RUBY)

Rubius Therapeutics Inc (RUBY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rubius Therapeutics Inc 399 BINNEY STREET SUITE 300 CAMBRIDGE MA 02139 USA

P: 617-679-9600

Description:

Rubius Therapeutics, Inc. is a bio-technology company. It develops cellular therapies for the treatment of auto-immune, metabolic and other diseases. Rubius Therapeutics, Inc. is based in Cambridge, United States.

Key Statistics

Overview:

Market Capitalization, $K 22,954
Enterprise Value, $K -126,746
Shares Outstanding, K 90,372
Annual Sales, $ 0 K
Annual Net Income, $ -196,550 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -62,873 K
60-Month Beta 2.32
% of Insider Shareholders 52.80%
% of Institutional Shareholders 76.11%
Float, K 42,656
% Float 47.20%
Short Volume Ratio 0.46

Growth:

1-Year Return -95.92%
3-Year Return -96.83%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/09/22
Next Earnings Date 02/24/23
Earnings Per Share ttm -1.44
EPS Growth vs. Prev Qtr 24.49%
EPS Growth vs. Prev Year 32.73%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

RUBY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -165.63%
Return-on-Assets % -74.93%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 2.10
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 0.00
Interest Coverage -29.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar